ARCHIVES

Academic Oncologists Losing Control Over Phase I Trials As For-Profits Expand

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

In Brief: Pretreatment Critical In Antimetic Therapy, Sallan Says; Aging/Cancer Symposium Planned

July 11, 1980

ACCC To Take In State Chapters, Forms Trials Group

April 6, 1990

AACR 2001 Honorary Awards Announced; Nora Janjan Is ASTRO President-Elect.

January 5, 2001

NAS To Honor Outstanding Scientists

February 28, 1997

Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting

October 26, 2007